作者
Tina Cascone,Mark M. Awad,Jonathan Spicer,Jie He,Shun Lü,Boris Sepesi,Fumihiro Tanaka,Janis M. Taube,Robin Cornelissen,Libor Havel,Nina Karaseva,Jarosław Kużdżał,Luboš Petruželka,Lin Wu,Jean-Louis Pujol,Hiroyuki Ito,Tudor–Eliade Ciuleanu,Ludmila de Oliveira Muniz Koch,Annelies Janssens,Aurelia Alexandru,Sabine Bohnet,Fedor V. Moiseyenko,Yang Gao,Yasutaka Watanabe,Cinthya Coronado Erdmann,Padma Sathyanarayana,S. Meadows–Shropshire,Steven I. Blum,Mariano Provencio
摘要
Standard treatment with neoadjuvant nivolumab plus chemotherapy significantly improves outcomes in patients with resectable non-small-cell lung cancer (NSCLC). Perioperative treatment (i.e., neoadjuvant therapy followed by surgery and adjuvant therapy) with nivolumab may further improve clinical outcomes.
不配.
薰硝壤
Singularity
Leonardi
可靠的书桃
paparazzi221
pluto
一一
完美的天空
HEIKU
pcr163
从容芮
ONESTUD
寻道图强
咖啡豆
彳亍1117
陈军
yufanhui
tuanheqi
8R60d8
皖公网安备34019202002308
